Teva Pharmaceuticals International GmbH et al v. Almaject Inc. et al
| Teva Pharmaceuticals International GmbH, Cephalon LLC, Eagle Pharmaceuticals, Inc. and Eagle Sub1 LLC |
| Almaject Inc. and Alvogen, Inc. |
| 1:2025cv01168 |
| September 18, 2025 |
| U.S. District Court for the District of Delaware |
| Jennifer L Hall |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 3, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,609,707; 9,265,831; 9,572,796; 9,572,797; 9,034,908. (Attachments: #1 Notice of Voluntary Dismissal)(ceg) |
| CASE CLOSED per D.I. #10 . (ceg) |
| Filing 10 NOTICE of Voluntary Dismissal by Cephalon LLC, Teva Pharmaceuticals International GmbH as to all claims and defenses asserted by Plaintiffs against Defendants (Golden, Ronald) |
| Filing 9 Unopposed MOTION for Extension of Time to answer, move, or otherwise respond to Complaint until March 4, 2026 - filed by Teva Pharmaceuticals International GmbH. (Golden, Ronald) |
SO ORDERED, re #9 Unopposed Motion for Extension of Time to answer, move, or otherwise respond to Complaint until March 4, 2026. (*Reset Answer Deadlines: Almaject Inc. answer due 3/4/2026; Alvogen, Inc. answer due 3/4/2026). Ordered by Judge Jennifer L. Hall on 1/23/2026. (ceg)
|
| Filing 8 WAIVER OF SERVICE returned executed by Teva Pharmaceuticals International GmbH, Cephalon LLC: For Alvogen, Inc. waiver sent on 12/4/2025, answer due 2/2/2026. (Golden, Ronald) |
| Filing 7 WAIVER OF SERVICE returned executed by Teva Pharmaceuticals International GmbH, Cephalon LLC: For Almaject Inc. waiver sent on 12/4/2025, answer due 2/2/2026. (Golden, Ronald) |
| Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (alb) |
| Filing 6 Summons Issued as to Almaject Inc. on 9/19/2025 & Alvogen, Inc. on 9/19/2025. (Attachments: #1 Summons Issued Alvogen, Inc.)(slk) |
| CORRECTING ENTRY: Summonses issued at D.I. 6 have been deleted due to an error found. Summonses will be reissued once corrected. (slk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries, Ltd., for Teva Pharmaceuticals International GmbH and Cephalon LLC; Corporate Parent Eagle Pharmaceuticals, Inc. for Eagle Sub1 LLC, filed by Cephalon LLC, Eagle Pharmaceuticals, Inc., Eagle Sub1 LLC, Teva Pharmaceuticals International GmbH. (Attachments: #1 7.1 Disclosure)(slk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,609,707; 9,265,831; 9,572,796; 9,572,797; 9,034,908. (slk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than August 6, 2025. Date of Expiration of Patent: 8,609,707 expires 8/11/2031, 9,265,831 expires 1/28/2031, 9,572,796 expires 1/28/2031, 9,572,797 expires 1/28/2031, 9,034,908 expires 3/15/2033, 9,144,568 expires 3/15/2033, 9,572,887 expires 3/15/2033, 9,597,397 expires 3/15/2033, 9,597,398 expires 3/15/2033, 9,597,399 expires 3/15/2033, 9,000,021 expires 3/15/2033, 9,579,384 expires 3/15/2033, 10,010,533 expires 1/28/2031, 10,052,385 expires 3/15/2033, 11,844,783 expires 1/28/2031, 11,872,214 expires 1/28/2031, 12,138,248 expires 1/28/2031, 12,350,257 expires 1/28/2031, 12,343,333 expires 1/28/2031.Thirty Month Stay Deadline: 2/6/2028. (slk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (slk) |
| Filing 1 COMPLAINT against Almaject Inc. & Alvogen, Inc. (Filing fee $ 405, receipt number ADEDC-4792848) - filed by Teva Pharmaceuticals International GmbH, Cephalon LLC, Eagle Pharmaceuticals, Inc., Eagle Sub1 LLC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L, #13 Exhibit M, #14 Exhibit N, #15 Exhibit O, #16 Exhibit P, #17 Exhibit Q, #18 Exhibit R, #19 Exhibit S, #20 Civil Cover Sheet)(slk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
